Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Chromosome engineering: prospects for gene therapy.

B R Grimes¹, P E Warburton, C J Farr

¹Department of Genetics, School of Medicine, Case Western Reserve University and University Hospital of Cleveland, Cleveland, OH 44106, USA.

|May 29, 2002

Summary

Researchers are advancing human artificial chromosome (HAC) technology for gene therapy. Progress in centromere function and construction methods offers an optimistic outlook for stable gene expression and therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data.

ESMO open·2026

Same author

Esperanto for histones: CENP-A, not CenH3, is the centromeric histone H3 variant.

Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology·2013

Same author

Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability.

Oncogene·2011

Same author

Pulsed-field and two-dimensional gel electrophoresis of long arrays of tandemly repeated DNA : analysis of human centromeric alpha satellite.

Methods in molecular biology (Clifton, N.J.)·2011

Same author

Interstitial deletion of proximal 8q including part of the centromere from unbalanced segregation of a paternal deletion/marker karyotype with neocentromere formation at 8p22.

Cytogenetic and genome research·2011

Same author

A neocentromere derived from a supernumerary marker deleted from the long arm of chromosome 6.

Cytogenetic and genome research·2007

Area of Science:

Genetics
Molecular Biology
Gene Therapy

Background:

The development of human artificial chromosomes (HACs) is crucial for gene therapy.
Ensuring mitotic stability of HACs through functional centromeres remains a key challenge.

Purpose of the Study:

To present recent advances in HAC construction and their potential for gene therapy.
To discuss the structure and function of human centromeres in the context of HACs.

Main Methods:

'Bottom up' construction: Transfer of circular PACs with alpha satellite DNA into HT1080 cells.
'Top down' construction: Telomere-associated chromosome fragmentation in DT40 cells to create small HACs.
Utilizing HACs for gene correction (HPRT deficiency) and stable transgene expression.

Related Experiment Videos

Main Results:

Demonstrated successful transfer and mitotic stability of HACs in cell lines.
Created HACs smaller than one megabase and achieved germline transmission in mice.
Showcased stable transgene expression using human minichromosomes.

Conclusions:

Significant progress has been made in HAC engineering for gene therapy applications.
While challenges persist, the outlook for HAC-based gene therapy is optimistic.